文献速递主动脉疾病

外科增强智能图可减少复杂主动脉瘤腔内治疗中的辐射并提高安全性

Use of surgical augmented intelligence maps can reduce radiation and improve safety in the endovascular treatment of complex aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2022-12-26

该回顾性研究纳入2015年8月至2021年11月在三级医疗中心接受复杂主动脉瘤、B型夹层或肾下腹主动脉腔内治疗的患者116例,按是否使用外科增强智能(AI)图分层。AI组76例(65.5%)与非AI组40例(34.5%)相比,辐射暴露、透视时间和对比剂用量均显著降低,手术时间数值降低但未达统计学显著,30天及长期结局无差异。

要点

  • AI组辐射暴露1955 mGy vs 非AI组3755 mGy,显著降低(P = .004)。
  • AI组透视时间55.6分钟 vs 非AI组86.9分钟,显著降低(P = .007)。
  • AI组对比剂用量123 mL vs 非AI组199 mL,显著降低(P < .0001)。

核心结论

  • 使用AI技术联合术中影像可显著减少复杂腔内动脉瘤修复的辐射暴露、透视时间和对比剂用量,并可能缩短手术时间。
  • AI等技术进步改善了患者和整个手术室团队的辐射安全。

研究设计与样本

  • 回顾性研究,纳入2015年8月至2021年11月在一家三级医疗中心接受复杂主动脉瘤(肾旁、近肾或胸腹)、B型夹层或肾下(内漏、弹簧圈置入或肾动脉造影伴或不伴介入)腔内治疗的患者116例。
  • 按是否使用患者特异性AI图(术中与实时透视图像联合使用)分层:AI组76例(65.5%),非AI组40例(34.5%)。
  • 主要结局为手术时间、辐射暴露、透视时间和对比剂用量;次要结局为30天术后并发症和长期随访;采用线性回归模型评估AI使用与主要结局的关联。

主要发现

  • 辐射暴露:AI组1955 mGy vs 非AI组3755 mGy,显著降低(P = .004)。
  • 透视时间:AI组55.6分钟 vs 非AI组86.9分钟,显著降低(P = .007)。
  • 手术时间:AI组255分钟 vs 非AI组284分钟,数值降低但未达统计学显著(P = .294)。
  • 对比剂用量:AI组123 mL vs 非AI组199 mL,显著降低(P < .0001)。
  • 30天和长期结局无差异。

临床怎么用

  • 作者认为,AI技术联合术中影像可通过减少手术时间、辐射暴露、透视时间和对比剂用量,显著促进复杂腔内动脉瘤修复。
  • 作者认为,AI等不断发展的技术改善了患者和整个手术室团队的辐射安全。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The introduction of endovascular procedures has revolutionized the management of complex aortic aneurysms. Although repair has traditionally required longer operative times and increased radiation exposure compared with simple endovascular aneurysm repair, the recent introduction of three-dimensional technology has become an invaluable operative adjunct. Surgical augmented intelligence (AI) is a rapidly evolving tool initiated at our institution in June 2019. In our study, we sought to determine whether this technology improved patient and operator safety. METHODS: A retrospective review of patients who had undergone endovascular repair of complex aortic aneurysms (pararenal, juxtarenal, or thoracoabdominal), type B dissection, or infrarenal (endoleak, coil placement, or renal angiography with or without intervention) at a tertiary care center from August 2015 to November 2021 was performed. Patients were stratified according to the findings from intelligent maps, which are patient-specific AI tools used in the operating room in conjunction with real-time fluoroscopic images. The primary outcomes included operative time, radiation exposure, fluoroscopy time, and contrast use. The secondary outcomes included 30-day postoperative complications and long-term follow-up. Linear regression models were used to evaluate the association between AI use and the main outcomes. RESULTS: During the 6-year period, 116 patients were included in the present study, with no significant differences in the baseline characteristics. Of the 116 patients, 76 (65.5%) had undergone procedures using AI and 40 (34.5%) had undergone procedures without AI software. The intraoperative outcomes revealed a significant decrease in radiation exposure (AI group, 1955 mGy; vs non-AI group, 3755 mGy; P = .004), a significant decrease in the fluoroscopy time (AI group, 55.6 minutes; vs non-AI group, 86.9 minutes; P = .007), a decrease in the operative time (AI group, 255 minutes; vs non-AI group, 284 minutes; P = .294), and a significant decrease in contrast use (AI group, 123 mL; vs non-AI group, 199 mL; P < .0001). No differences were found in the 30-day and long-term outcomes. CONCLUSIONS: The results from the present study have demonstrated that the use of AI technology combined with intraoperative imaging can significantly facilitate complex endovascular aneurysm repair by decreasing the operative time, radiation exposure, fluoroscopy time, and contrast use. Overall, evolving technology such as AI has improved radiation safety for both the patient and the entire operating room team.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel RJ, Lee AM, Hallsten J, et al. Use of surgical augmented intelligence maps can reduce radiation and improve safety in the endovascular treatment of complex aortic aneurysms. J Vasc Surg. 2022. PMID: 36581011. doi:10.1016/j.jvs.2022.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。